What are the recommended antibiotics for the treatment of Pyelonephritis (infection of the kidney)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended antibiotics for the treatment of Pyelonephritis are fluoroquinolones and cephalosporins.

Treatment Options

  • For oral empiric treatment of uncomplicated pyelonephritis, fluoroquinolones (such as ciprofloxacin or levofloxacin) and cephalosporins are recommended 1.
  • For patients with uncomplicated pyelonephritis requiring hospitalization, initial treatment with an intravenous antimicrobial regimen such as a fluoroquinolone, an aminoglycoside (with or without ampicillin), or an extended-spectrum cephalosporin or penicillin is recommended 1.

Specific Regimens

  • Suggested regimens for empirical oral antimicrobial therapy for uncomplicated pyelonephritis include:
    • Ciprofloxacin: 500-750 mg twice daily for 7 days
    • Levofloxacin: 750 mg once daily for 5 days
    • Cefpodoxime: 200 mg twice daily for 10 days
    • Ceftibuten: 400 mg once daily for 10 days 1
  • Suggested regimens for empirical parenteral antimicrobial therapy for uncomplicated pyelonephritis include:
    • Ciprofloxacin: 400 mg twice daily
    • Levofloxacin: 750 mg once daily
    • Ceftriaxone: 1-2 g once daily
    • Cefepime: 1-2 g twice daily 1

Considerations

  • The choice of antibiotic should be based on local resistance patterns and optimized 1.
  • Fluoroquinolone resistance should be less than 10% for empirical use 1.
  • Alternative dosing strategies, such as 5-day or 7-day courses, may be effective, but further study is needed 1.

From the Research

Recommended Antibiotics for Pyelonephritis

The following antibiotics are recommended for the treatment of pyelonephritis:

  • Aminoglycosides 2, 3
  • Amino- or carboxypenicillins (alone or associated with clavulanic acid) 2
  • Ureidopenicillins (e.g. mezlocillin, piperacillin) 2
  • Fluoroquinolones (e.g. ciprofloxacin, ofloxacin, pefloxacin) 2, 3, 4, 5, 6
  • Cephalosporins 2, 4, 5, 6
  • Monobactams (e.g. aztreonam) 2
  • Carbapenems (e.g. imipenem) 2
  • The combination of trimethoprim plus a sulphonamide [e.g. cotrimoxazole (trimethoprim/sulfamethoxazole)] 2, 3, 4

Specific Recommendations

  • For outpatient oral antibiotic therapy, fluoroquinolones, extended-spectrum penicillins, amoxicillin-clavulanate potassium, cephalosporins, and trimethoprim-sulfamethoxazole are effective alternatives 4
  • For inpatient treatment, intravenous treatment is recommended with a fluoroquinolone, aminoglycoside with or without ampicillin, or a third-generation cephalosporin 4
  • For acute uncomplicated pyelonephritis in women, oral fluoroquinolones (ciprofloxacin or ofloxacin) or injectable third-generation cephalosporin ceftriaxone are recommended as first-choice empirical antibiotic treatment 5
  • Alternative treatments/novel dosing regimens for oral antibiotics, such as amoxicillin, amoxicillin-clavulanic acid, cephalexin, and fosfomycin trometamol, may be considered based on pharmacokinetic-pharmacodynamic assessments 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of pyelonephritis in adults.

The Medical clinics of North America, 1995

Research

A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.